517MO Phase I study of the porcupine (PORCN) inhibitor RXC004 in patients with advanced solid tumoursNatalie Cook, Ruth Plummer, Louise Goodwin et al.|Annals of Oncology|2021Cited by 10
600TiP A first-in-human study of, NUC-7738, a 3'-dA phosphoramidate, in patients with advanced solid tumours (NuTide:701)Stefan Symeonides, Sarah P. Blagden, Francesca Aroldi et al.|Annals of Oncology|2020Cited by 1